Clean Science and Technology Limited: history, ownership, mission, how it works & makes money

From a Pune-based private startup in 2003 to a publicly listed specialty-chemicals player on the NSE as CLEAN, Clean Science and Technology Limited's journey is punctuated by precise milestones - incorporated on 7 Nov 2003, renamed in 2006, converted to a public company in Feb-Mar 2021 and led by promoter-executive Ashok Ramnarayan Boob alongside fellow promoters KrishnaKumar Boob, Siddharth Sikchi and Parth Maheshwari; its operational footprint of three certified Kurkumbh units, independent R&D and quality labs underpins proprietary catalytic processes (including vapor‑phase hydrogenation and patented eco‑catalysts), Zero Liquid Discharge effluent systems, rainwater harvesting and a commissioned 5 MW solar plant (Mar 2023) that dovetail with sustainability goals, while capacity additions - Unit‑3's HALS 770 and 4‑Hydroxy Tempo (701) totaling 2,000 MT (Dec 2022) and the December 2024 commercialization of BHT and DHDT lines - signal strategic moves into pharmaceutical intermediates; with equity shares of face value ₹1 freely tradable, a varied shareholder base and export channels across Asia, Europe and North America, CSTL monetizes its eco‑friendly, scalable processes by selling premium specialty chemicals to polymers, coatings, FMCG, pharma and agro customers, leveraging economies of scale, value engineering and ongoing capex to expand market share.

Clean Science and Technology Limited (CLEAN.NS): Intro

• Founded in Pune and evolved from a private chemical player into a publicly listed specialty chemicals company focused on high-margin, technically complex molecules.
• Key value drivers: product purity and selectivity, captive upstream integration, sustainable energy footprint and export-focused clientele.

History and Major Milestones

Ownership and Corporate Structure

• Promoter background: founders and promoter group established the company in Pune and retained strategic operational control through major shareholdings as the company transitioned public.
• Shareholding architecture: a typical structure includes promoters, institutional investors, and public shareholders following the public transition in 2021 (promoters retain a majority stake to maintain strategic control).

Mission and Strategic Focus

• Mission: manufacture high-purity specialty chemicals via sustainable, low-waste processes and offer backward-integrated solutions for global customers.
• Strategic pillars:
  • Product differentiation through high selectivity and purity.
  • Backward integration for critical intermediates to secure supply and margin.
  • Energy efficiency and renewables-evidenced by a 5 MW solar installation.
  • Focused commercialization of high-value molecules (HALS, TEMPO derivatives, BHT, DHDT).

How It Works - Manufacturing, Products and Capacity

• Manufacturing model: multi-unit, captive-feed production with licensed and proprietary chemistries enabling scale-up from kilo to tonne scale while meeting strict quality and regulatory standards.
• Key product categories:
  • Performance additives: Hindered Amine Light Stabilizers (HALS) such as HALS-770 - used in polymers and coatings for UV stabilization.
  • Radical scavengers and antioxidants: Butylated Hydroxy Toluene (BHT) - antioxidant for polymer and pharma intermediates.
  • Redox and radical reagents: 4-Hydroxy TEMPO (701) and other TEMPO derivatives - used in fine chemical and pharma syntheses.
  • Pharmaceutical intermediates: Dihydroxy Diphenyl Triazine (DHDT) - commercialized to address high-purity pharma demand.
• Notable production capacities and assets:
  • Unit-3 (commissioned Dec 2022) - 2,000 MT/year capacity for HALS-770 and 4-Hydroxy TEMPO.
  • BHT and DHDT plants commercialized in Dec 2024 (commissioning marks entry into certain pharma intermediate segments).
  • 5 MW rooftop/ground-mounted solar power plant commissioned Mar 2023 to supply a portion of captive power needs.

How It Makes Money - Revenue Streams and Economics

• Primary revenue drivers:
  • Sales of proprietary specialty molecules and intermediates to global chemical, polymer and pharmaceutical manufacturers.
  • Higher-margin products from captive backward-integrated routes (reduced dependence on third-party intermediates).
  • Export-focused model-substantial proportion of sales to international customers demanding consistent high-purity chemistry.
• Profitability levers:
  • Scale-up of complex chemistries that command price premiums over commodity chemicals.
  • Energy cost reduction through the 5 MW solar plant and process efficiencies.
  • Product portfolio expansion (e.g., BHT, DHDT) to capture adjacencies and improve capacity utilization.

Selected Operational and Capacity Snapshot

Markets, Clients and Competitive Position

• Customer profile: global formulators, polymer producers, pharmaceutical intermediates manufacturers and specialty chemical distributors requiring high-purity materials and regulatory compliance.
• Competitive advantages:
  • Capability to manufacture technically demanding molecules at commercial scale.
  • Focus on eco-friendly, efficient processes and captive raw material pathways.
  • Diversification into antioxidants and pharma intermediates to reduce product-concentration risk.

Clean Science and Technology Limited (CLEAN.NS): History

• Listed on the National Stock Exchange of India (NSE) under the ticker 'CLEAN'.
• Equity shares have a face value of ₹1 each, facilitating liquidity and free trading.
• Shareholder base includes institutional investors, retail shareholders and company insiders-no dominant external corporate parent or cross-holding.

• Promoter / promoter-family executives occupy senior operating roles (MD/Executive Director and other executive positions).
• Institutional investors (mutual funds, insurance, foreign institutional investors) and retail investors form the rest of the public float.
• Capital structure is equity‑centric with ₹1 face value shares enabling straightforward market liquidity and trading.

Clean Science and Technology Limited (CLEAN.NS): Ownership Structure

• Mission: Develop innovative, sustainable, cost-effective catalytic manufacturing processes for specialty chemicals with minimal environmental footprint.
• Core values: sustainability, innovation, transparency, employee development, and social responsibility.
• R&D emphasis: continuous process optimization, value engineering to improve yields, reduce raw material use and energy intensity.

• Corporate governance: publicly listed with a board comprising independent directors, regular disclosures, and audit committees to ensure accountability.
• CSR activities: tree plantation drives, water conservation projects, and local community engagement programs.

• Manufacturing and selling specialty chemicals produced via proprietary catalytic processes that command premium margins due to efficiency, yield and green credentials.
• Contract manufacturing and tolling arrangements for global customers seeking low-cost, compliant suppliers.
• Value-added services from process development and custom synthesis derived from in-house R&D capability.

Clean Science and Technology Limited (CLEAN.NS): Mission and Values

• Manufacturing footprint: three certified production facilities clustered at Kurkumbh (Maharashtra), each with independent R&D units and dedicated quality control laboratories to enable rapid scale-up from lab to commercial batches.
• Proprietary processes: CSTL employs vapor-phase hydrogenation, selective catalytic hydrogenations, and patented eco‑friendly catalysts to achieve high yields, selectivity, and lower waste streams compared with conventional batch chemistries.
• Supply‑chain control: in‑house synthesis of key intermediates, vendor rationalization, and strategic raw‑material sourcing reduce input cost volatility and improve on-time delivery performance for contract and captive customers.

• Effluent and water management: state-of-the-art Effluent Treatment Plants (ETPs) at all manufacturing units achieving Zero Liquid Discharge (ZLD), combined with rainwater harvesting and internal recycling loops to minimize freshwater withdrawal.
• Energy and process efficiency: measures include reduced process heat utilization, waste‑heat recovery, and process optimization to minimize water evaporation losses and lower specific energy consumption per tonne of product.
• R&D and QC integration: each manufacturing unit's R&D and QC ensures tight process control, continuous improvement, and faster troubleshooting-supporting both new product development and scale-up reproducibility.

• Sale of specialty chemicals: high‑purity intermediates and specialty molecules sold to global pharmaceutical, agrochemical, and fine‑chemical customers-products typically command higher gross margins than commodity chemicals.
• Contract manufacturing and toll processing: scale‑up and dedicated production runs for customers under long‑term agreements or multi‑year purchase contracts, providing predictable capacity utilization.
• Proprietary product licensing and technical services: revenue from licensing proprietary catalysts/processes and providing technical support for downstream formulators.
• Optimized product mix and yield improvements: higher contribution margins are realized through process intensification, improved product yields, and reduced raw‑material and waste disposal costs.

Clean Science and Technology Limited (CLEAN.NS): How It Works

• Proprietary process technology: CSTL develops proprietary syntheses and solvent-free or low-waste routes that reduce raw material consumption and regulatory burden, enabling premium pricing.
• Large-scale, modular manufacturing: Multi-site plants with high-capacity reactors and downstream units create economies of scale and flexibility to switch across product families.
• End-market diversification: Products are tailored for polymers, coatings, food additives, cosmetics, personal care, fragrances, pharma and agrochemical intermediates, reducing customer concentration risk.
• Export-led commercial strategy: A majority of sales are to overseas customers, leveraging long-term contracts, technical collaborations and a global distribution network.
• Value engineering & cost optimization: Continuous process improvement, backward integration for key intermediates and procurement scale drive margin improvement.

• Performance chemicals - high-value additives for polymers, coatings and stabilizers (including HALS).
• FMCG chemicals - aroma chemicals, fragrance ingredients and specialty intermediates used in personal care and cosmetics.
• Pharmaceutical & agro intermediates - niche building blocks and intermediates for APIs and crop protection molecules.
• New product expansion - targeted launches such as DHDT and other specialty intermediates aimed at adjacent markets to lift wallet share.

• Manufacturing & exports: Primary revenue source is sale of specialty chemicals manufactured in-house and exported to global customers across multiple industries.
• Premium pricing from proprietary tech: Proprietary, cleaner processes permit higher realizations versus commodity peers.
• Scale-led cost advantage: Large plants and optimized feedstock sourcing reduce per-unit costs and increase gross margin.
• Product mix shift & innovation: Adding new higher-value lines (e.g., HALS, DHDT) drives ASP (average selling price) uplift and recurring demand.
• Service & technical support: Application development and co-development agreements underpin repeat orders and long-term contracts.

• Polymers & plastics: stabilizers, additives
• Coatings & paints: performance additives, ultraviolet stabilizers
• Food & flavours: edible-grade intermediates and solvents
• Personal care & cosmetics: aroma chemicals, specialty emollients
• Pharmaceuticals & agrochemicals: intermediates and API building blocks
• Automotive & construction: specialty additives and functional chemicals

• Product mix: Shifting revenue toward higher-margin specialties and HALS/DHDT raises blended realizations.
• Process efficiency: Yield, cycle-time and energy-cost improvements reduce COGS per kg.
• Backward integration: Securing intermediate feedstocks lowers input-price volatility exposure.
• Scale and utilization: Higher plant utilization spreads fixed costs and lifts operating leverage.
• Geographic diversification: Broader export markets mitigate single-region demand shocks.

• Long-term offtake agreements: Multi-year supply contracts with overseas formulators that provide predictable volumes and pricing frameworks.
• Technical collaboration: Co-development and application-support contracts that lock customers into proprietary ingredients.
• Spot exports & distributor channels: Complementary route to market for smaller customers and new geographies.

Clean Science and Technology Limited (CLEAN.NS): How It Makes Money

• Core revenue drivers: production and sale of specialty chemicals used in active pharmaceutical ingredients (APIs), agrochemicals, and fine chemical intermediates.
• Geographic diversification: significant export focus-products shipped to Asia, Europe and North America-supporting foreign-currency revenue and scale economics.
• Value capture: premium pricing for high-purity, low-impurity products and multi-year supply agreements with global customers.

• Sustainability edge: investments in green process chemistry, solvent recovery and lower-waste manufacturing align the company with rising global demand for eco-friendly chemical inputs.
• CapEx-led growth: ongoing capital expenditure on new plants and debottlenecking aims to expand installed capacity and broaden the product mix-supporting medium-term revenue and margin expansion.
• Competitive dynamics: faces competition from domestic specialty-chemical players and international multinationals, but maintains differentiation through innovation, quality and customer intimacy.

• Scale and mix: leveraging specialized capacity to capture premium pricing and margins versus commodity chemicals.
• Export-led volume growth: higher overseas sales improve utilization and unit economics.
• New product introductions and custom synthesis/toll contracts: expand addressable market and deepen customer relationships.